Literature DB >> 31107243

Academia and industry: allocating credit for discovery and development of new therapies.

Jeffrey S Flier.   

Abstract

Mesh:

Year:  2019        PMID: 31107243      PMCID: PMC6546481          DOI: 10.1172/JCI129122

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  7 in total

Review 1.  Augmenting reference pricing of pharmaceuticals in New Zealand with strategic cross-product agreements.

Authors:  A Woodfield
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 2.  Reproducibility in science: improving the standard for basic and preclinical research.

Authors:  C Glenn Begley; John P A Ioannidis
Journal:  Circ Res       Date:  2015-01-02       Impact factor: 17.367

3.  Pricing in the Market for Anticancer Drugs.

Authors:  David H Howard; Peter B Bach; Ernst R Berndt; Rena M Conti
Journal:  J Econ Perspect       Date:  2015

4.  Innovation in the pharmaceutical industry: New estimates of R&D costs.

Authors:  Joseph A DiMasi; Henry G Grabowski; Ronald W Hansen
Journal:  J Health Econ       Date:  2016-02-12       Impact factor: 3.883

Review 5.  Fundamental science behind today's important medicines.

Authors:  Jonathan M Spector; Rosemary S Harrison; Mark C Fishman
Journal:  Sci Transl Med       Date:  2018-04-25       Impact factor: 17.956

6.  Irreproducibility of published bioscience research: Diagnosis, pathogenesis and therapy.

Authors:  Jeffrey S Flier
Journal:  Mol Metab       Date:  2016-11-21       Impact factor: 7.422

7.  Why most published research findings are false.

Authors:  John P A Ioannidis
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.613

  7 in total
  4 in total

1.  The Resurrection of Phenotypic Drug Discovery.

Authors:  Wayne E Childers; Khaled M Elokely; Magid Abou-Gharbia
Journal:  ACS Med Chem Lett       Date:  2020-03-06       Impact factor: 4.345

Review 2.  An urgent call to raise the bar in oncology.

Authors:  John-John B Schnog; Michael J Samson; Rijk O B Gans; Ashley J Duits
Journal:  Br J Cancer       Date:  2021-08-16       Impact factor: 7.640

3.  Public research funding and pharmaceutical prices: do Americans pay twice for drugs?

Authors:  Rena M Conti; Frank S David
Journal:  F1000Res       Date:  2020-07-15

Review 4.  Transformative dynamism in pharmaceutical and biomedical research: Complexity of integration of innovative R & D hubs.

Authors:  Yadollah Omidi; Hossein Omidian
Journal:  Bioimpacts       Date:  2021-02-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.